SCHEMBL3973512

SCHEMBL3973512

NNC(=O)c1c(C(=O)OC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)ccc(O)c1I

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
GAA P10253 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3981614 0.91 ALOX15 (0.34) ALOX15ALOX12GAA
SCHEMBL3982435 0.90 ALOX15 (0.38) ALOX15ALOX12GAA
SCHEMBL3982135 0.89 MEN1 (0.34) ALOX15ALOX12GAATSHR
SCHEMBL3981082 0.89 MEN1 (0.34) ALOX15ALOX12GAA
SCHEMBL3983196 0.88 HSD17B1 (0.32) ALOX15ALOX12GAA
SCHEMBL3983965 0.88 ALOX15 (0.32) ALOX15ALOX12GAA
SCHEMBL3977753 0.86 PDE4B (0.35) GAA
SCHEMBL3975937 0.85 ALDH1A1 (0.36) ALOX15ALOX12GAATSHR
SCHEMBL3977868 0.85 ALOX15 (0.31) ALOX15ALOX12
SCHEMBL3978772 0.85 TACR1 (0.31) ALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ALOX15 2249/4885ALOX12 2483/4885GAA 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.